Samuel D. Isaly is Director at INTERCEPT PHARMACEUTICALS INC (ICPT). They have made 49 open-market trades across 26 companies since 2006, most recently 2018-01-03.
CIK 0001055949
18 open-market purchases totalling $59.5M since 2007, against 31 sales. Across 13 scored buys the stock is down 2.4% at ninety days, and 3.7 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 46% | 31% |
| Avg Move | -4.2% | +0.9% | -2.4% |
| Alpha | -1.7% | -0.2% | -3.7% |
| Scored | 13 | 13 | 13 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 35% | 38% |
| Avg Move | +5.3% | +1.3% | -2.0% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PIRS | SELL | 2018-01-03 | 2018-01-04 | $7.35 | $25.1M | -2.6% | +6.1% | -12.3% |
| LOXO | SELL | 2017-11-16 | 2017-11-20 | $74.33 | $36.9M | -1.0% | +4.2% | +34.4% |
| RYTM | BUY | 2017-10-10 | 2017-10-10 | $17.00 | $6.0M | -12.2% | -16.3% | +5.8% |
| BOLD | SELL | 2017-09-29 | 2017-09-29 | $28.25 | $19.0M | -1.2% | -7.9% | +13.7% |
| ROKA | SELL | 2017-09-26 | 2017-09-28 | $1.00 | $202K | +147.7% | +56.5% | -12.7% |
| GKOS | SELL | 2017-09-05 | 2017-09-05 | $39.09 | $16.6M | -19.4% | -12.3% | -33.6% |
| GKOS | SELL | 2017-09-01 | 2017-09-05 | $37.72 | $4.1M | -19.4% | -12.3% | -33.6% |
| GKOS | SELL | 2017-08-31 | 2017-09-05 | $37.82 | $1.7M | -19.4% | -12.3% | -33.6% |
| GKOS | SELL | 2017-08-31 | 2017-09-05 | $38.73 | $22.5M | -19.4% | -12.3% | -33.6% |
| KALA | BUY | 2017-07-25 | 2017-07-27 | $15.00 | $4.8M | +4.6% | +18.9% | -13.1% |
| ADAP | BUY | 2017-03-27 | 2017-03-28 | $4.20 | $10.0M | +15.9% | +13.0% | -2.0% |
| PrivateAerpio Pharmaceuticals, Inc. | BUY | 2017-03-15 | 2017-03-17 | $5.00 | $3.8M | N/A | N/A | N/A |
| GKOS | SELL | 2017-03-03 | 2017-03-07 | $47.05 | $5.2M | +11.1% | +14.9% | -14.3% |
| VRAY | BUY | 2017-01-18 | 2017-01-20 | $3.00 | $992K | +24.8% | +20.5% | +66.0% |
| RLYP | SELL | 2016-07-22 | 2016-07-26 | $32.00 | $129.4M | -0.2% | -0.1% | N/A |
| SELB | BUY | 2016-06-27 | 2016-06-29 | $14.00 | $7.7M | -2.2% | -23.3% | +8.1% |
| NTLA | BUY | 2016-05-11 | 2016-05-13 | $18.00 | $4.5M | +23.7% | +13.0% | -24.1% |
| RLYP | SELL | 2015-12-21 | 2015-12-23 | $27.18 | $13.6M | -30.6% | -28.9% | -49.9% |
| DMTX | BUY | 2015-10-27 | 2015-10-29 | $13.00 | $2.6M | -32.1% | -7.1% | -35.8% |
| RLYP | BUY | 2015-10-22 | 2015-10-22 | $12.56 | $6.3M | -30.6% | +0.6% | -28.1% |
| SIEN | SELL | 2015-10-12 | 2015-10-13 | $5.98 | $1.7M | +32.0% | +0.0% | +33.0% |
| SIEN | SELL | 2015-10-02 | 2015-10-06 | $8.71 | $1.7M | +32.0% | +0.0% | +0.0% |
| SIEN | SELL | 2015-09-29 | 2015-10-01 | $10.24 | $1.0M | +32.0% | +0.0% | +0.0% |
| SIEN | SELL | 2015-09-24 | 2015-09-28 | $10.58 | $1.6M | +32.0% | +0.0% | +0.0% |
| PIRS | BUY | 2015-07-06 | 2015-07-08 | $2.75 | $1.4M | -25.0% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| MRTX | 1,172,000 | $68.8M |
| CTIC | 5,000,000 | $45.5M |
| DMTX | 5,397,698 | $32.1M |
| SUPN | 817,000 | $30.9M |
| NTLA | 2,412,180 | $27.5M |
| ICPT | 1,120,609 | $21.3M |
| BOLD | 4,129,638 | $9.6M |
| AMRN | 825,756 | $9.3M |
| SELB | 1,280,604 | $1.1M |
| KALA | 2,055,946 | $386K |
| ADAP | 6,149,377 | $338K |
| ATHX | 3,180,000 | $324K |
| ROKA | 6,379 | $4K |
| SIEN | 17,100 | $3K |
| VRAY | 89,225 | $2K |
| AVN | 1,706,137 | — |
| CRYO | 389,432 | — |
| ARYX | 2,125,493 | — |
| ANTH | 2,915,000 | — |
| DOVP | 548,000 | — |
| AMBI | 14,067 | — |
| PrivateUnlisted | 4,416,446 | — |
| Total | $1.4B |
Shares reported on the most recent Form 4, priced at the 2018-01-04 close. 7 holdings could not be priced and are excluded from the total.
| Scored | 17 | 17 | 16 |